| Authors |
Title of the Paper |
Source |
Number of Citations |
| Sadler J.E., Budde U., Srivastava A., et al |
Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand factor |
Journal of Thrombosis and Haemostasis 2006, 4(10), 2103-2114 |
266 |
| Kumar S., Bandyopadhyay U. |
Free heme toxicity and its detoxification systems in human |
Toxicology Letters 2005, 157(3), 175-188 |
136 |
Rodeghiero F., Castaman G., Srivastava A.
et al |
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: An international, multicenter study |
Journal of Thrombosis and Haemostasis 2005, 3(12), 2619-2626 |
100 |
McCaughan G.W., Amarapurkar D., Chutaputti A.,
et al |
Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection |
Journal of Gastroenterology and Hepatology 2007, 22(5), 615-633 |
58 |
Premawardhena A., Verma I.C
et al |
The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): Hematologic and evolutionary implications |
Blood Cells, Molecules, and Diseases 2003, 31(1), 98-101 |
57 |
| Srivastava A., Poonkuzhali B., Shaji R.V. et al |
Glutathione S-transferase M1 polymorphism: A risk factor for hepatic venoocclusive disease in bone marrow transplantation |
Blood 2004, 104(5), 1574-77 |
53 |
Baronciani L., Cozzi G., Srivastava A.
et al |
Molecular defects in type 3 von Willebrand disease: Updated results from 40 multiethnic patients |
Blood Cells, Molecules, and Diseases 2003, 30(3), 264-270 |
48 |
Peyvandi F., Jayandharan G., Chandy M., Srivastava A.
et al |
Genetic diagnosis of haemophilia and other inherited bleeding disorders |
Haemophilia 2006, 12 (Suppl 3), 82-89 |
37 |
| Dixit A., Chatterjee T.C., Mishra P. et al |
Hydroxyurea in thalassemia intermedia - A promising therapy |
Annals of Hematology 2005, 84(7), 441-46 |
37 |
Tiwari A., Bansal V., Chugh A.,
et al |
Statins and myotoxicity: A therapeutic limitation |
Expert Opinion on Drug Safety 2006, 5(5), 651-66 |
36 |
| Kakkar P., Jaffery F.N. |
Biological markers for metal toxicity |
Environmental Toxicology and Pharmacology 2005, 19(2), 335-39 |
36 |
| Pandian J.D., Padma V., Vijaya P. et al |
Stroke and thrombolysis in developing countries |
International Journal of Stroke 2007, 2(1), 17-26 |
32h |
| Kalantri S.P., Joshi R., Riley L.W. |
Chikungunya epidemic: An Indian perspective |
National Medical Journal of India 2006, 19(6), 315-22 |
30 |
